Boston Scientific Corporation BSX
Set alert
44.32 USD +2.34 +5.57%
At close
44.15 -0.17 -0.38%
Pre-market · Nov 3, 6:07 AM ET
41.90 Day range 44.36
39.57 52-week range 105.65
- YTD
- -53.52%
- 1 year
- -55.05%
- Open
- 42.07
- Prev close
- 41.98
- Mkt cap
- 64.23B
- Vol
- 22.71M
- Avg vol
- 19.60M
- EPS
- 2.37
- P/E
- 18.70
- Div yield
- 0.00%
More statistics
- Low
- 41.90
- High
- 44.36
- Forward P/E
- 14.10
- Beta
- 0.58
- Short ratio
- 2.17
- Inst. own
- 94.97%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 3, 2027
- 50-d avg
- 44.79
- 200-d avg
- 56.52
- 1y target
- 50.03
5Y chart
Events in this range
- Oct 22, 2025Earnings: 0.75; estimate 0.714; surprise 5.04%
- Feb 4, 2026Earnings: 0.8; estimate 0.781; surprise 2.43%
- Apr 22, 2026Earnings: 0.8; estimate 0.788; surprise 1.52%
- Jul 29, 2026Earnings: 0.86; estimate 0.835; surprise 2.99%
- Oct 28, 2026Earnings: 0.73; estimate 0.727; surprise 0.41%
- Oct 29, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 29, 2026Rating: Bernstein · Outperform → Outperform
- Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
- Oct 29, 2026Downgrade: Jefferies · Buy → Hold
- Oct 30, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 30, 2026Downgrade: TD Cowen · Buy → Hold
Signals (94)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| RSI: Oversold | May 25, 2026 | 5 months ago |
| RSI: Oversold | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 4, 2025 | 1 year ago |
Newest 20 of 94.
Analyst view
Consensus: buy
Buy
Price target (mean) 50.03 +12.9% upside
Now 44.32
- Target (low)
- 41.00
- Target (mean)
- 50.03
- Target (high)
- 65.00
Ratings (0m) 31 20 buy · 11 hold · 0 sell
- Strong buy6
- Buy14
- Hold11
- Sell0
- Strong sell0
Recommendation trend
- This month 31
- 1 month ago 31
- 2 months ago 31
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.77555 | 0.76864 – 0.79 | 0.80 | -3.1% | 5.18B | -2.0% | 24 |
| Next quarter | 0.74429 | 0.70 – 0.78 | 0.80 | -7.0% | 5.06B | -2.7% | 17 |
| Current year | 3.18 | 3.15 – 3.29 | 3.06 | +3.8% | 20.97B | +4.4% | 28 |
| Next year | 3.15 | 3.02 – 3.62 | 3.18 | -0.7% | 21.03B | +0.3% | 29 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | TD Cowen | Downgrade | Buy | Hold |
| Oct 30, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | Jefferies | Downgrade | Buy | Hold |
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 29, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Oct 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 29, 2026 | UBS | Maintained | Buy | Buy |
| Oct 29, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 29, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 28, 2026 | Needham | Maintained | Buy | Buy |
| Oct 26, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 14, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Equal-Weight |
| Oct 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Sep 24, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 21, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 17, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Sep 9, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 25, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Jul 31, 2026 | Argus Research | Downgrade | Buy | Hold |
| Jul 30, 2026 | UBS | Maintained | Buy | Buy |
| Jul 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 30, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 30, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |